ScholarIQanswers from OpenAlex
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD
PaperCitations, authors & open-access status
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD have?
ScholarIQcitation count
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has 60 citations in the OpenAlex counts ScholarIQ stores.
When was Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD published?
ScholarIQyear
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has 2022 year in the ScholarIQ index.
What is the open-access status of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?
ScholarIQoa status
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD has green oa status in the ScholarIQ index.
What is the DOI of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?
ScholarIQdoi
The DOI for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.
What is the PMID of Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?
ScholarIQpmid
The PMID for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.
What is the OpenAlex record for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD?
ScholarIQopenalex
The OpenAlex for Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD is on the source record.